Repros completes direct public offering

Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Business: Genitourinary, Endocrine/Metabolic Date completed: 2/2/12 Type: Direct public offering Raised: $11.1 million Shares: 2.5 million ...